We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Feeling lucky?

12 Apr 2006 By Robert Cyran

Funds are piling into Schering, the German drug maker being taken over by Bayer. They aim to hold the deal to ransom in hope of more cash. This is an old wheeze. But unlike prior cases such as Wella or Celanese, the upside seems relatively small this time.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)